CD44 and hepatocellular carcinoma: In HCC, CD44 is TIC marker most associated with the epithelial-mesenchymal transition (EMT), drug resistance and tumor formation in immunodeficient mice [9–11], suggesting that CD44 expression might be a crucial sign to guide clinical treatment.